Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Cascinelli, N. (1995). Evaluation of efficacy of adjuvant rlFNa-2a in melanoma patients with regional lymph node metastases. Proc Am Soc Clin Oncol 14: A1296 (abstract)
Creagan, E. T., Dalton, R. J., Ahmann, D. L., Jung, S. H., Morton, R. F., Langdom, R. M. Jr, Kugler, J. & Rodrigue, L. J. (1995). Randomized, surgical adjuvant clinical trial of recombinant interferon α-2a in selected patients with malignant melanoma. J Clin Oncol 13: 2776
Kirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Bordern, E. C. & Blum, R. H. (1996). Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Co-operative Oncology Group trial EST 1684. J Clin Oncol 14: 7–17.
Ravaud, A., Bedane, C., Geoffrois, L., Lesimple, T. & Delauney, M. (1999). Toxicity and feasibility of adjuvant high dose interferon alpha-2b in patients with melanoma in clinical oncological practice. Br J Cancer 80: 1767–1769.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Middleton, M. Adjuvant interferon in the treatment of melanoma. Br J Cancer 80, 1679–1680 (1999). https://doi.org/10.1038/sj.bjc.6690582
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690582
This article is cited by
-
The inhibin-βC subunit is down-regulated, while inhibin-βE is up-regulated by interferon-β1a in Ishikawa carcinoma cell line
Archives of Gynecology and Obstetrics (2013)
-
Preventing relapse in melanoma
Current Oncology Reports (2000)
